This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market
Opthotech Corporation is researching a new therapy for wet-stage age-related macular degeneration that could have blockbuster potential.
In Case You Missed It, Breast Cancer Detection Just Took a Gigantic Leap Forward
When battling breast cancer, time is of the essence. That's why the discovery of this new breast cancer detection technique really is that big of a deal.
This Popular Beverage Could Be Responsible For a 20% Reduction in Melanoma Risk
The good news: this beverage reduced the risk of an aggressive form of skin cancer by 20% in a very large study. The better news: 83% of you are already consuming this beverage on a daily basis!
These 3 Pharmaceutical Companies Control Roughly Half of All Cancer Drug Sales
Global cancer drug sales totaled $91 billion in 2013 and are expected to breach $100 billion in sales sooner than you think. Yet, three big pharmaceutical companies currently control about half of all cancer drug sales.
Here's Why This Year's Flu Vaccine Isn't Working
Have you ever wondered why the effectiveness of the flu vaccine is so erratic from one year to the next? Here's the answer.
State of the Union Address Investing Idea: Precision Medicine
There are plenty of companies developing precision medicine drugs already, and investors would be wise to watch key players.
3 Warning Signs You've Invested in a Dangerous Biotech Stock
Three Motley Fool analysts help investors spot biotech stock warning signals.
Will Organovo Holdings Inc. be Bought Out in 2015?
It could happen, but here's why long-term investors should ignore this noise anyway.
Can You Guess Which Big Pharma Has a More Robust Pipeline Than Pfizer, Inc.?
Pfizer's pipeline currently features 86 clinical studies and/or registrations. That's an incredible figure that demonstrates Pfizer's commitment to R&D. But, it's also not the most robust pipeline in the pharmaceutical sector. Can you guess which big pharma company has an even larger pipeline than Pfizer?